Skip to content
    LGND stock page

    LIGAND PHARMACEUTICALS INC

    LGND · earnings call history

    3 calls analysed
    1. Jun 2026Q2 FY26Aug 06, 2026

      Ligand Q2 FY26 — XOMA Acquisition and Strong Royalty Growth Drive EPS Outlook Increase

      Read the brief
    2. Mar 2026Q1 FY26May 07, 2026

      Ligand Q1 FY26 — XOMA Acquisition and Key Product Milestones Drive Growth

      Read the brief
    3. Dec 2025Q4 FY25Feb 26, 2026

      Ligand Pharmaceuticals Q4 FY25 — Strong Royalty Growth and Reaffirmed 2026 Guidance

      Read the brief

    Browse all US companies on the earnings-call register.